EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 34 (October 2018) Focus issue F1 Med Sci (Paris), 34 (2018) 121-133 References
Free Access
Issue
Med Sci (Paris)
Volume 34, October 2018
Cancer biomarkers
Page(s) 121 - 133
DOI https://doi.org/10.1051/medsci/201834f121
Published online 07 November 2018
  1. Valeyre D. et al. Sarcoidosis. Lancet 2014 ; 383 : 9923 1155–1167. [CrossRef] [PubMed] [Google Scholar]
  2. Iannuzzi M.C. Rybicki B.A. Teirstein A.S. Sarcoidosis. N Engl J Med 2007 ; 357 : 21 2153–2165. [CrossRef] [PubMed] [Google Scholar]
  3. Baughman R.P. et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001 ; 164 : 10 Pt 1 1885–1889. [CrossRef] [PubMed] [Google Scholar]
  4. Mana J. et al. Cutaneous involvement in sarcoidosis. Relationship to systemic disease. Arch Dermatol 1997 ; 133 : 7 882–888. [Google Scholar]
  5. Lodha S. Sanchez M. Prystowsky S. Sarcoidosis of the skin: a review for the pulmonologist. Chest 2009 ; 136 : 2 583–596. [CrossRef] [PubMed] [Google Scholar]
  6. Costabel U. Guzman J. Baughman R.P. Systemic evaluation of a potential cutaneous sarcoidosis patient. Clin Dermatol 2007 ; 25 : 3 303–311. [CrossRef] [PubMed] [Google Scholar]
  7. Chappell A.G. Cheung W.Y. Hutchings H.A. Sarcoidosis: a long-term follow up study. Sarcoidosis Vasc Diffuse Lung Dis 2000 ; 17 : 2 167–173. [PubMed] [Google Scholar]
  8. Broos C.E. et al. Granuloma Formation in Pulmonary Sarcoidosis. Frontiers in Immunology 2013 ; 4 : 437. [CrossRef] [PubMed] [Google Scholar]
  9. Lockstone H.E. et al. Gene set analysis of lung samples provides insight into pathogenesis of progressive, fibrotic pulmonary sarcoidosis. Am J Respir Crit Care Med 2010 ; 181 : 12 1367–1375. [CrossRef] [PubMed] [Google Scholar]
  10. Swigris J.J. et al. Sarcoidosis-related mortality in the United States from 1988 to 2007. Am J Respir Crit Care Med 2011 ; 183 : 11 1524–1530. [CrossRef] [PubMed] [Google Scholar]
  11. Huang C.T. et al. Mortality in sarcoidosis. A changing pattern of the causes of death. Eur J Respir Dis 1981 ; 62 : 4 231–238. [PubMed] [Google Scholar]
  12. Arcasoy S.M. et al. Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation. Chest 2001 ; 120 : 3 873–880. [CrossRef] [PubMed] [Google Scholar]
  13. Iwai K. et al. Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 1994 ; 11 : 1 26–31. [PubMed] [Google Scholar]
  14. Brownell I. et al. Evidence for mycobacteria in sarcoidosis. Am J Respir Cell Mol Biol 2011 ; 45 : 5 899–905. [CrossRef] [PubMed] [Google Scholar]
  15. Gupta D. et al. Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysis. Eur Respir J 2007 ; 30 : 3 508–516. [CrossRef] [PubMed] [Google Scholar]
  16. Newman L.S. et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 2004 ; 170 : 12 1324–1330. [CrossRef] [PubMed] [Google Scholar]
  17. Chen E.S. Moller D.R. Sarcoidosis–scientific progress and clinical challenges. Nat Rev Rheumatol 2011 ; 7 : 8 457–467. [CrossRef] [PubMed] [Google Scholar]
  18. Zhou Y. et al. Human leukocyte antigen-A, -B, and -DRB1 alleles and sarcoidosis in Chinese Han subjects. Hum Immunol 2011 ; 72 : 7 571–575. [CrossRef] [PubMed] [Google Scholar]
  19. Grunewald J. Eklund A. Role of CD4+ T cells in sarcoidosis. Proc Am Thorac Soc 2007 ; 4 : 5 461–464. [CrossRef] [Google Scholar]
  20. Piotrowski W.J. et al. TGF-beta and SMADs mRNA Expression in Pulmonary Sarcoidosis. Adv Exp Med Biol 2015 ; 852 : 59–69. [CrossRef] [PubMed] [Google Scholar]
  21. Judson, M.A., et al., Molecular profiling and gene expression analysis in cutaneous sarcoidosis: the role of interleukin-12, interleukin-23, and the T-helper 17 pathway. J Am Acad Dermatol, 2012. 66(6): p. 901–10, 910.e1-2. [CrossRef] [PubMed] [Google Scholar]
  22. Piotrowski, W.J., et al., Expression of HIF-1A/VEGF/ING-4 Axis in Pulmonary Sarcoidosis. Adv Exp Med Biol, 2015. [Google Scholar]
  23. Imai H. Kaira K. Minato K. Clinical significance of post-progression survival in lung cancer. Thorac Cancer 2017 ; 8 : 379–386. [CrossRef] [PubMed] [Google Scholar]
  24. Crouser E.D. et al. Gene expression profiling identifies MMP-12 and ADAMDEC1 as potential pathogenic mediators of pulmonary sarcoidosis. Am J Respir Crit Care Med 2009 ; 179 : 10 929–938. [CrossRef] [PubMed] [Google Scholar]
  25. Eickhoff S.B. et al. Analysis of neurotransmitter receptor distribution patterns in the cerebral cortex. Neuroimage 2007 ; 34 : 4 1317–1330. [CrossRef] [PubMed] [Google Scholar]
  26. Chen, E.S. and D.R. Moller, Etiologies of Sarcoidosis. Clin Rev Allergy Immunol, 2015. [Google Scholar]
  27. Ma Y. Gal A. Koss M.N. The pathology of pulmonary sarcoidosis: update. Semin Diagn Pathol 2007 ; 24 : 3 150–161. [CrossRef] [PubMed] [Google Scholar]
  28. Morgenthau A.S. Iannuzzi M.C. Recent advances in sarcoidosis. Chest 2011 ; 139 : 1 174–182. [CrossRef] [PubMed] [Google Scholar]
  29. Rybicki B.A. et al. Familial risk ratio of sarcoidosis in African-American sibs and parents. Am J Epidemiol 2001 ; 153 : 2 188–193. [CrossRef] [Google Scholar]
  30. Rybicki B.A. et al. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997 ; 145 : 3 234–241. [CrossRef] [Google Scholar]
  31. Sverrild A. et al. Heredity in sarcoidosis: a registry-based twin study. Thorax 2008 ; 63 : 10 894–896. [CrossRef] [PubMed] [Google Scholar]
  32. Newman L.S. et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 2004 ; 170 : 12 1324–1330. [CrossRef] [PubMed] [Google Scholar]
  33. Crouser E.D. et al. Differential expression of microRNA and predicted targets in pulmonary sarcoidosis. Biochem Biophys Res Commun 2012 ; 417 : 2 886–891. [CrossRef] [Google Scholar]
  34. Loke W.S.J. Herbert C. Thomas P.S. Sarcoidosis: Immunopathogenesis and Immunological Markers. International Journal of Chronic Diseases 2013 ; 2013 : 13. [Google Scholar]
  35. Ringkowski S. Thomas P.S. Herbert C. Interleukin-12 family cytokines and sarcoidosis. Front Pharmacol 2014 ; 5 : 233. [PubMed] [Google Scholar]
  36. Naumnik, W., et al., Interleukin-33 as a New Marker of Pulmonary Sarcoidosis. Adv Exp Med Biol, 2015. [Google Scholar]
  37. Fischer, A., et al., Identification of Immune-relevant Factors Conferring Sarcoidosis Genetic Risk. Am J Respir Crit Care Med, 2015. [Google Scholar]
  38. Mana J. et al. Granulomatous cutaneous sarcoidosis: diagnosis, relationship to systemic disease, prognosis and treatment. Sarcoidosis Vasc Diffuse Lung Dis 2013 ; 30 : 4 268–281. [PubMed] [Google Scholar]
  39. Kaarteenaho-Wiik R. Soini Y. Claudin-1, -2, -3, -4, -5, and -7 in Usual Interstitial Pneumonia and Sarcoidosis. Journal of Histochemistry and Cytochemistry 2009 ; 57 : 3 187–195. [CrossRef] [Google Scholar]
  40. Hidaka K. et al. An adjacent pair of human NUDT genes on chromosome X are preferentially expressed in testis and encode two new isoforms of diphosphoinositol polyphosphate phosphohydrolase. J Biol Chem 2002 ; 277 : 36 32730–32738. [CrossRef] [PubMed] [Google Scholar]
  41. Foley P.J. et al. Analysis of MHC encoded antigen-processing genes TAP1 and TAP2 polymorphisms in sarcoidosis. Am J Respir Crit Care Med 1999 ; 160 : 3 1009–1014. [CrossRef] [PubMed] [Google Scholar]
  42. Foley P. et al. HLA-DPB1 and TAP1 polymorphisms in sarcoidosis. Chest 1997 ; 111 : 6 Suppl 73S. [CrossRef] [PubMed] [Google Scholar]
  43. Gungor S. et al. Conventional markers in determination of activity of sarcoidosis. Int Immunopharmacol 2015 ; 25 : 1 174–179. [CrossRef] [PubMed] [Google Scholar]
  44. Wessendorf T.E. Bonella F. Costabel U. Diagnosis of Sarcoidosis. Clin Rev Allergy Immunol 2015 ; 49 : 1 54–62. [CrossRef] [PubMed] [Google Scholar]
  45. Li S. Sun X. Miao S. Liu J. Jiao W. Differential protein-coding gene and long noncoding RNA expression in smoking-related lung squamous cell carcinoma. Thorac Cancer 2017 ; 8 : 672–681. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.